{"id":"W2183796916","doi":"10.1016/j.clml.2015.11.008","title":"Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network; McMaster University; Juravinski Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Alemtuzumab; Medicine; CD52; CHOP; Gastroenterology; Internal medicine; Cyclophosphamide; Vincristine; Chemotherapy; Urology; Transplantation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003057812,0.001842452,0.002549524,0.0006239515,0.0004416714,0.001110598,0.001205698,0.001415977,0.002176256],"category_scores_gemma":[0.001181141,0.0007173845,0.001348703,0.0007087847,0.001224375,0.001037026,0.0004508912,0.002683297,0.0005655268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009423286,"about_ca_system_score_gemma":0.001765546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000734666,"about_ca_topic_score_gemma":0.001320539,"domain_scores_codex":[0.9991019,0.0005161914,0.00004886631,0.0001183547,0.00008160872,0.000133191],"domain_scores_gemma":[0.9986908,0.0002106885,0.0002432677,0.0001371688,0.00005878697,0.0006593741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6188362,0.1745218,0.01378839,0.001027284,0.002683387,0.0004818758,0.0005249109,0.004615379,0.05160161,0.0002027673,0.001981886,0.1297344],"study_design_scores_gemma":[0.4777649,0.5042201,0.01231798,0.00003525526,0.0005675771,0.0003272524,0.00003890978,0.001250413,0.002186985,0.00009906242,0.001167349,0.0000241565],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959199,0.001406767,0.0004508498,0.0001659386,0.00004605637,0.001304421,0.0001874697,0.00004764505,0.0004709103],"genre_scores_gemma":[0.9914615,0.002134125,0.001712625,0.0006043992,0.0002425558,0.002126597,0.0009021441,0.00002703709,0.0007890188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003057812,"threshold_uncertainty_score":0.01617146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07798139945745185,"score_gpt":0.3917010295346585,"score_spread":0.3137196300772066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}